Lack of phencyclidine-induced effects in mice with reduced neuronal nitric oxide synthase

Psychopharmacology

Volumn 155, Issue 3, 2001, Pages 299-309

  Bird, D C ^a   Bujas Bobanovic, M ^a   Robertson, H A ^a   Dursun, S M ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Antisense; Behaviour; c Fos; Knockout mice; Nitric oxide; Phencyclidine

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE SYNTHASE; PHENCYCLIDINE; PROTEIN C FOS;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; LOCOMOTION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SCHIZOPHRENIA; STEREOTYPY;

ANIMALS; ATAXIA; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION; GENES, FOS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; OLIGONUCLEOTIDES, ANTISENSE; PHENCYCLIDINE; STEREOTYPED BEHAVIOR;

EID: 0035007592     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100705     Document Type: Article

References (83)

1. Adams B, Moghaddam B (1998) Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci 18:5545-5554
2. Aguan K, Mahesh VB, Ping L, Bhat G, Brann DW (1996) Evidence for a physiological role for nitric oxide in the regulation of the LH surge: effect of central administration of antisense oligonucleotides to nitric oxide synthase. Neuroendocrinology 64:449-455
3. Alagarsamy S, Lonart G, Johnson KM (1994) Regulation of nitric oxide synthase activity in cortical slices by excitatory amino acids and calcium. J Neurosci Res 38:648-653
4. Andreasen NC (1997) The role of the thalamus in schizophrenia. Can J Psychiatry 42:27-33
5. Bakshi VP, Swedlow NR, Geyer MA (1994) Clozapine antagonizes phencyclidine induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271:787-794
6. Bakshi VP, Tricklebank M, Neijt HC, Lehmann MV, Geyer MA (1999) Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-D-aspartate receptor antagonists in rats. J Pharmacol Exp Ther 288:643-652
7. Bredt DS, Hwang PM, Snyder SH (1990) Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347:768-770
8. Bredt DS, Glatt CE, Hwang PM, Fotuhi M, Dawson TM, Snyder SH (1991) Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 7:615-624
9. Brenman JE, Chao DS, Gee SH, McGee AW, Craven S, Santillano DR, Wu Z, Huang F, Xia H, Peters MF, Froehner SC, Bredt DS (1996) Interaction of nitric oxide synthase with the post-synaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Cell 84:757-767
10. Brenman JE, Xia H, Chao DS, Black SM, Bredt DS (1997) Regulation of neuronal nitric oxide synthase through alternative transcripts. Dev Neurosci 19:224-231
11. Brysch E (1999) The design of appropriate control experiments to ensure specificity in antisense oligonucleotide function. In: Leslie R, Hunter A, Robertson HA (eds) Antisense technology in the central nervous system. Oxford University Press, New York, pp 21-41
12. Bujas-Bobanovic M, Bird DC, Robertson HA, Dursun SM (2000) Blockade of phencyclidine-induced effects by a nitric oxide donor. Br J Pharmacol 130:1005-1012
13. Bujas-Bobanovic M, Robertson HA, Dursun SM (2001) Effect of nitric oxide synthase inhibitor N-nitro-L-arginine methyl ester on phencyclidine-induced effects in rats. Eur J Pharmacol (in press)
14. Carlsson A, Hansson LO, Waters N, Carlsson ML (1999) A glutamatergic deficiency model of schizophrenia. Br J Psychiatry 174:2-6
15. Chetty C, Hussain S, Slikker W, Ali S (1995) Effects of phencyclidine on nitric oxide activity in different regions of rat brain. Res Commun Alcohol Subst Abuse 16:105-114
16. Crooke S (2000) Progress in antisense technology: the end of the beginning. In: Phillips M (ed) Antisense technology. Academic Press, San Diego, pp 3-45
17. Curran T, Morgan JI (1995) Fos: an immediate-early transcription factor in neurons. J Neurobiol 26:403-412
18. Curzon P, Decker MW (1998) Effects of phencyclidine (PCP) and (+)MK-801 on sensorimotor gating in CD-1 mice. Prog Neuropsychopharmacol Biol Psychiatry 22:129-146
19. Danysz W, Wroblewski JT, Brooker G, Costa E (1989) Modulation of glutamate receptors by phencyclidine and glycine in the rat cerebellum: cGMP increase in vivo. Brain Res 479:270-276
20. Dawson TM, Dawson VL (1996) Nitric oxide synthase: Role as a transmitter/mediator in the brain and endocrine system. Annu Rev Med 47:219-227
21. Dawson TM, Snyder SH (1994) Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J Neurosci 14:5147-5159
22. Deakin JF, Slater P, Simpson MD, Gilchrist AC, Skan WJ, Royston MC, Reynolds GP, Cross AJ (1989) Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J Neurochem 52:1781-1786
23. Deutsch SI, Rosse RB, Paul SM, Riggs RL, Mastropaolo J (1997) Inbred mouse strains differ in sensitivity to "popping" behavior elicited by MK-801. Pharmacol Biochem Behav 57:315-317
24. Dragunow M, Peterson M, Robertson H (1987) Localization and induction of c-Fos protein-like immunoreactive nuclei in adult rat brain. Eur J Pharmacol 135:113-114
25. Dursun SM, McIntosh D, Milliken H (1999) Clozapine plus lamotrigine in treatment-resistant schizophrenia. Arch Gen Psychiatry 56:950
26. Ellenbroek BA, Geyer ME, Cools AR (1995) The behavior of APO-SUS rats in animal model with construct validity for schizophrenia. J Neurosci 15:7604-7611
27. Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic Press, San Diego
28. Freed WJ, Weinberger D, Bing L, Wyatt R (1980) Neuropharmacological studies of phencyclidine (PCP)-induced behavioral stimulation in mice. Psychopharmacology 71:291-297
29. Freed WJ, Bing LA, Wyatt RJ (1984) Effects of neuroleptics on phencyclidine (PCP)-induced locomotor stimulation in mice. Neuropharmacology 23:175-181
30. Gao XM, Hashimoto T, Tamminga CA (1998) Phencyclidine (PCP) and dizocilpine (MK801) exert time-dependent effects on the expression of immediate early genes in rat brain. Synapse 29:14-28
31. Gerlai R (1996) Gene-targeting studies of mammalian behavior: is it mutation or background genotype? Trends Neurosci 19:177-181
32. Geyer MA, Markou A (1994) Animal models of psychiatric disorders. In: Bloom FE, KDL (eds) Psychopharmacology, the fourth generation of progress. Raven Press, New York, pp 787-798
33. Gleason SD, Shannon HE (1997) Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology 129:79-84
34. Haley TJ, McCormick WG (1957) Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol 12:12-15
35. Hebb MO, Robertson HA (1997) End-capped antisense oligodeoxynucleotides effectively inhibit gene expression in vivo and offer a low-toxicity alternative to fully modified phosphorothioate oligodeoxynucleotides. Mol Brain Res 47:223-228
36. Hirsch SR, Das I, Garey LJ, de Belleroche J (1997) A pivotal role for glutamate in the pathogenesis of schizophrenia, and its cognitive dysfunction. Pharmacol Biochem Behav 56:797-802
37. Ho S, Hartig P (1999) Antisense knockdown in the CNS - optimizing the strategy. In: Leslie R, Hunter A, Robertson HA (eds) Antisense technology in the central nervous system. Oxford University Press, New York, pp 8-18
38. Hu PS, Ross SB (1997) NMDA receptor-mediated increase in cyclic GMP in the rat cerebellum in vivo is blocked by alaproclate and GEA-857. Pharmacol Toxicol 80:97-102
39. Huang PL, Lo EH (1998) Genetic analysis of NOS isoforms using nNOS and eNOS knockout animals. Prog Brain Res 118:13-25
40. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC (1993) Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75:1273-1286
41. Itzhak Y, Ali SF, Martin JL, Black MD, Huang PL (1998a) Resistance of neuronal nitric oxide synthase-deficient mice to cocaine-induced locomotor sensitization. Psychopharmacology 140:378-386
42. Itzhak Y, Gandia C, Huang PL, Ali SF (1998b) Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. J Pharmacol Exp Ther 284:1040-1047
43. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308
44. Jentsch JD, Roth RH (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20:201-225
45. Johansson C, Jackson DM, Svensson L (1997) Nitric oxide synthase inhibition blocks phencyclidine-induced behavioural effects on prepulse inhibition and locomotor activity in the rat. Psychopharmacology 131:167-173
46. Johansson C, Deveney AM, Reif D, Jackson DM (1999) The neuronal selective nitric oxide inhibitor AR-R 17477, blocks some effects of phencyclidine, while having no observable behavioural effects when given alone. Pharmacol Toxicol 84:226-233
47. Kolesnikov YA, Pan YX, Babey AM, Jain S, Wilson R, Pasternak GW (1997) Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance. Proc Natl Acad Sci USA 94:8220-8225
48. Kriegsfeld LJ, Eliasson MJ, Demas GE, Blackshaw S, Dawson TM, Nelson RJ, Snyder SH (1999) Nocturnal motor coordination deficits in neuronal nitric oxide synthase knock-out mice. Neuroscience 89:311-315
49. Lane P, Gross SS (1999) Cell signaling by nitric oxide. Semin Nephrol 19:215-229
50. Leslie R, Jones D (1997) Antisense gene knockdown in the central nervous system: optimism for the future. Trends Neurosci 20:320-322
51. Moghaddam B, Adams BW (1998) Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281:1349-1352
52. Mohn AR, Gainetdinov PR, Caron MG, Koller BH (1999) Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98:427-436
53. Nakki R, Sharp FR, Sagar SM (1996a) Fos expression in the brainstem and cerebellum following phencyclidine and MK801. J Neurosci Res 43:203-212
54. Nakki R, Sharp FR, Sagar SM, Honkaniemi J (1996b) Effects of phencyclidine on immediate early gene expression in the brain. J Neurosci Res 45:13-27
55. Nelson RJ, Demas GE, Huang PL, Fishman MC, Dawson VL, Dawson TM, Snyder SH (1995) Behavioral abnormalities in male mice lacking neuronal nitric oxide synthase. Nature 378:383-386
56. Nestler EJ, Gao XM, Tamminga CA (1997) Molecular biology, V. Immediate early genes. Am J Psychiatry 154:312-342
57. Noda Y, Yamada K, Furukawa H, Nabeshima T (1995) Involvement of nitric oxide in phencyclidine-induced hyperlocomotion in mice. Eur J Pharmacol 286:291-297
58. Noda Y, Yamada K, Komori Y, Sugihara H, Furukawa H, Nabeshima T (1996) Role of nitric oxide in the development of tolerance and sensitization to behavioural effects of phencyclidine in mice. Br J Pharmacol 117:1579-1585
59. Osawa Y, Davila JC (1993) Phencyclidine, a psychotomimetic agent and drug of abuse, is a suicide inhibitor of brain nitric oxide synthase. Biochem Biophys Res Commun 194:1435-1439
60. Pande M, Cameron JA, Vig PJ, Ali SF, Desaiah D (1999) Inhibition of calcium ATPase by phencyclidine in rat brain. Mol Cell Biochem 194:173-177
61. Redmond AM, Harkin A, Kelly JP, Leonard BE (1999) Effects of acute and chronic antidepressant administration on phencyclidine (PCP) induced locomotor hyperactivity. Eur Neuropsychopharmacol 9:165-170
62. Robertson GS, Matsumura H, Fibiger HC (1994) Induction patterns of fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharmacol Exp Ther 271:1058-1066
63. Rosenblum WI, Murata S (1996) Antisense evidence for two functionally active forms of nitric oxide synthase in brain microvascular endothelium. Biochem Biophys Res Commun 224:535-543
64. Ryabinin AE, Wang YM, Finn DA (1999) Different levels of fos immunoreactivity after repeated handling and injection stress in two inbred strains of mice. Pharmacol Biochem Behav 63:143-151
65. Sagar S, Sharp R, Curran T (1988) Expression of c-Fos protein in brain: metabolic mapping at the cellular level. Science 240:1328-1331
66. Sams-Dodd F (1995) Distinct effects of d-amphetamine and phencyclidine on the social behaviour of rats. Behav Pharmacol 6:55-65
67. Sams-Dodd F (1996) Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia. Behav Pharmacol 7:3-23
68. Sams-Dodd F (1999) Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity. Rev Neurosci 10:59-90
69. Schlemmer RF, Davis JM (1983) A comparison of three psychotomimetic-induced models of psychosis in nonhuman primate social colonies. Prog Clin Biol Res 131:33-78
70. Sharp JW (1997) Phencyclidine (PCP) acts at sigma sites to induce c-Fos gene expression. Brain Res 758:51-58
71. Silbersweig D, Stern E (1996) Functional neuroimaging of hallucinations in schizophrenia-toward on integration of bottom-up and top-down approaches. Mol Psychiatry 1:367-375
72. Steinpreis RE (1996) The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis. Behav Brain Res 74:45-55
73. Sugita S, Namima M, Nabeshima T, Okamoto K, Furukawa H, Watanabe Y (1996) Phencyclidine-induced expression of c-Fos-Like immunoreactivity in mouse brain regions. Neurochem Int 28:545-550
74. Swerdlow NR, Bakshi VP, Geyer MA (1996) Seroquel restores sensorimotor gating in phencylidine-treated rats. J Pharmacol Exp Ther 279:1290-1299
75. Tamminga C (1998) Schizophrenia and glutamatergic transmission. Crit Rev Neurobiol 12:21-36
76. Tamminga C (1999) Glutamatergic aspects of schizophrenia. Br J Psychiatry 174:12-15
77. Thornberg SA, Saklad SR (1996) A review of NMDA receptors and the phencyclidine model of schizophrenia. Pharmacotherapy 16:82-93
78. Turgeon SM, Roche JK (1999) The delayed effects of phencyclidine enhance amphetamine-induced behavior and striatal C-Fos expression in the rat. Neurosci 91:1265-1275
79. Wang Y, Newton DC, Marsden PA (1999) Neuronal NOS: gene structure, mRNA diversity, and functional relevance. Crit Rev Neurobiol 13:21-43
80. Widzowski D, Weaver J, Walton J (1999) L-NAME blocks PCP-induced locomotor activity more potently than L-nitroarginine and other NOS inhibitors. 29th Annual Meeting, Society for Neuroscience (Miami Beach: Society for Neuroscience), pp 1876
81. Wiley JL, Kogut CP, Witherell JR (1999) Effects of acute and repeated dosing with PCP on locomotion in nNOS knockout mice. 29th Annual Meeting, Society for Neuroscience (Miami Beach: Society for Neuroscience), pp 946
82. Wroblewski JT, Nicoletti F, Fadda E, Costa E (1987) Phencyclidine is a negative allosteric modulator of signal transduction at two subclasses of excitatory amino acid receptors. Proc Natl Acad Sci USA 84:5068-5072
83. Yen SH, Pan JT (1999) Nitric oxide plays an important role in the diurnal change of tuberoinfundibular dopaminergic neuronal activity and prolactin secretion in ovariectomized, estrogen/progesterone-treated rats. Endocrinology 140:286-291